Skip over navigation
The Hospital
Research
Support Us
Ottawa Hospital Research Institute
Home
Français
Directions & Maps
Contact Us
About Us
Vision and Strategic Directions
Board Chair and CEO Message
Leadership Team
Annual Reports
Facilities
Research Data Management
Equity, Diversity and Inclusion
Wellness
Our Research
Priorities, Programs and Diseases
Researcher Profiles
National Research Networks
Scientific Publications
Research Awards
Technology Transfer
Industry Sponsored Research
Responsible Innovation
For Students & Fellows
News & Events
Newsroom
Seminars & Events
Career Opportunities
For Patients
News & Events
Home
>
News & Events
>
Newsroom
Bookmark or Share
Display Options
Display Options
+
Increase
/
-
Decrease
font size
High contrast version
Printer-friendly version
Newsroom
Seminars & Events
Newsroom
Simple treatment for extreme nosebleeds far cheaper, improves patient experience
February 5, 2014
Dr. Shaun Kilty and colleagues have found an effective way to treat serious nosebleeds in the emergency department, reducing patient discomfort and avoiding costly hospital stays. A city the size of Ottawa will encounter an estimated 1,500 nosebleeds that require a doctor’s visit, with up to 160 of those requiring hospitalization for as much as three days. Dr. Kilty’s small clinical trial, published in
The Laryngoscope
,
showed that using a product called gelatin-thrombin matrix (commonly used in surgery to control bleeding) is just as effective as existing treatment options, simpler to administer, between 80% and 90% less costly, and results in the patient leaving the hospital one hour after the treatment.
Funder:
Baxter Corporation
About the Ottawa Hospital Research Institute
The Ottawa Hospital Research Institute (OHRI) is the research arm of The Ottawa Hospital and is an affiliated institute of the University of Ottawa, closely associated with the university’s Faculties of Medicine and Health Sciences. OHRI includes more than 1,700 scientists, clinical investigators, graduate students, postdoctoral fellows and staff conducting research to improve the understanding, prevention, diagnosis and treatment of human disease.
Media contact
Jennifer Ganton
Director, Communications and Public Relations
Ottawa Hospital Research Institute
613-798-5555 x 73325
613-614-5253 (cell)
jganton@ohri.ca